Previous close | 97.00 |
Open | 97.00 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 610.00 |
Expiry date | 2024-12-20 |
Day's range | 97.00 - 97.00 |
Contract range | N/A |
Volume | |
Open interest | 1 |
IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the animal diagnostic equipment maker expects a hit from a slowdown in veterinary clinic visits by pet owners and a stronger dollar. Visits to veterinary clinics, after a COVID-driven boom, have been disrupted due to staffing shortages in the past few years. IDEXX lowered its full-year revenue forecast to between $3.9 billion and $3.97 billion from its previous estimate of $3.93 billion to $4.04 billion.
Comprehensive Analysis of IDEXX's First Quarter Financial Performance
WESTBROOK, Maine, May 01, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results.